Upregulation of endothelin converting enzyme-1 in host liver during chronic cardiac allograft rejection

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 899-901

  Lattmann, Thomas ^a   Ortmann, Jana ^a   Horber, Sibylle ^a   Shaw, Sidney G ^b   Hein, Marc ^c   Barton, Matthias ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

ECE; Heart; Organ; Systemic; Transplantation

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARDIAC GRAFT REJECTION; CONFERENCE PAPER; CONTROLLED STUDY; HEART TRANSPLANTATION; HISTOCOMPATIBILITY COMPLEX; HOUSEKEEPING GENE; IMMUNE DEFICIENCY; LIVER CLEARANCE; NONHUMAN; PLASMA CLEARANCE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ASPARTIC ENDOPEPTIDASES; CHRONIC DISEASE; ENDOTHELIN-1; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAFT REJECTION; HEART TRANSPLANTATION; LIVER; METALLOENDOPEPTIDASES; RATS; RATS, INBRED F344; RATS, INBRED LEW; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

ANIMALIA;

EID: 33744916989     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Barton M, Kiowski W. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease. Curr Hypertens Rep 3:322-330, 2001.
2. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485, 1994.
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
4. Camargos ERS, Rocha LL, Rachid MA, Almeida AP, Ferreira AJ, Teixeira Jr AL, Chiari E, Barton M, Teixeira MM, Machado CR. Protective role of ET(A) endothelin receptors during the acute phase of Trypanosoma cruzi infection in rats. Microbes Infect 6:650-656, 2004.
5. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection - an undefined conundrum. Transplantation 52:389-398, 1991.
6. Guttmann RD, Forbes RD, Zheng SX. The pathophysiology of chronic rejection. Am J Med Sci 313:302-304, 1997.
7. Watschinger B, Sayegh MH, Hancock WW, Russell ME. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol 146:1065-1072, 1995.
8. Watschinger B, Sayegh MH. Endothelin in organ transplantation. Am J Kidney Dis 27:151-161, 1996.
9. Simonson MS, Herman WH, Robinson A, Schulak J, Hricik DE. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts. Transplantation 67:1542-1547, 1999.
10. Lattmann T, Hein M, Horber S, Ortmann J, Teixeira MM, Souza DG, Haas E, Tornillo L, Munter K, Vetter W, Barton M. Activation of proinflammatory and anti-inflammatory cytokines in host organs during chronic allograft rejection: role of endothelin receptor signaling. Am J Transplant 5:1042-1049, 2005.
11. Shao R, Shi Z, Gotwals PJ, Koteliansky VE, George J, Rockey DC. Cell and molecular regulation of endothelin-1 production during hepatic wound healing. Mol Biol Cell 14:2327-2341, 2003.
12. Molet S, Furukawa K, Maghazechi A, Hamid Q, Giaid A. Chemokine-and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells. J Allergy Clin Immunol 105(2 Pt 1):333-338, 2000.
13. Woods M, Mitchell JA, Wood EG, Barker S, Walcot NR, Rees GM, Warner TD. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Mol Pharmacol 55:902-909, 1999.
14. Adams DH, Tilney NL, Collins JJ Jr, Karnovsky MJ. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model. Transplantation 53:1115-1119, 1992.
15. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85:9797-9800, 1988.
16. Marsen TA, Weber F, Egink G, Suckau G, Baldamus CA. Cyclosporin A induces prepro endothelin-1 gene transcription in human endothelial cells. Eur J Pharmacol 379:97-106, 1999.